Adverum Biotechnologies
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
WACHTER PAUL director
 Common Stock 1,192 $40.19 $47,910
Sale
BLUMENKRANZ MARK S. director
 Common Stock 25,000 $41.81 $1,045,325
Sale
ZYGTECH, LLC 10 percent owner
 Common Stock 4,600 $39.93 $183,664
Option
GASMI MEHDI director
 Stock Option (Right to Buy) 1,000 $2.75 $2,750
Sale
GASMI MEHDI director
 Common Stock 1,000 $2.75 $2,750
Option
GASMI MEHDI director
 Common Stock 1,000 $2.75 $2,750
Sale
ZYGTECH, LLC 10 percent owner
 Common Stock 20,400 $39.91 $814,184
Sale
WACHTER PAUL director
 Common Stock 1,192 $39.89 $47,554
Sale
SCHWARTZ STEVEN DANIEL director
 Common Stock 17,250 $40.05 $690,828
Sale
BLUMENKRANZ MARK S. director
 Common Stock 2,500 $39.94 $99,840
Sale
BLUMENKRANZ MARK S. director
 Common Stock 23,500 $38.82 $912,364
Option
GASMI MEHDI director
 Stock Option (Right to Buy) 9,000 $2.75 $24,750
Sale
GASMI MEHDI director
 Common Stock 9,000 $38.82 $349,416
Option
GASMI MEHDI director
 Common Stock 9,000 $2.75 $24,750
Option
HULL HANS officer: Chief Executive Officer
 Common Stock 27,500 $0.19 $5,225
Sale
HULL HANS officer: Chief Executive Officer
 Common Stock 27,500 $38.82 $1,067,660
Option
HULL HANS officer: Chief Executive Officer
 Stock Option (Right to Buy) 27,500 $0.19 $5,225
Sale
ZYGTECH, LLC 10 percent owner
 Common Stock 100,000 $55.46 $5,546,000
Sale
CHALBERG THOMAS W. director, officer: Chief Execut..
 Common Stock 85,000 $55.46 $4,714,100
Sale
WACHTER PAUL director
 Common Stock 14,000 $55.46 $776,440
Sale
SCHWARTZ STEVEN DANIEL director
 Common Stock 91,000 $55.46 $5,046,860
Sale
BLUMENKRANZ MARK S. director
 Common Stock 100,000 $55.46 $5,546,000
Option
CHALBERG THOMAS W. director, officer: Chief Execut..
 Common Stock 413 $0.21 $87
Option
CHALBERG THOMAS W. director, officer: Chief Execut..
 Stock Option (Right to Buy) 413 $0.21 $87
Purchase
FLYNN JAMES E 10 percent owner, other: Possib..
 Common Stock 1,334,467 $23.83 $31,803,018
Purchase
VENROCK ASSOCIATES VI, L.P. 10 percent owner
 Common Stock 400,000 $17 $6,800,000
Purchase
REGENERON PHARMACEUTICALS INC 10 percent owner
 Common Stock 588,235 $17 $9,999,995
Purchase
VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. 10 percent owner
 Common Stock 400,000 $17 $6,800,000

Showing 150 to 178 of 178 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: